Skip to content

Multimodal Ayurvedic management of Plaque psoriasis

A Multimodal Ayurvedic intervention in Plaque psoriasis - a single arm open label clinical study - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/12/060767
Enrollment
30
Registered
2023-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L408- Other psoriasis

Interventions

None listed

Sponsors

Krupaben S. Kagda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient willing to participate in clinical trial 2.Patient having clinical signs and symptoms of Plaque psoriasis

Exclusion criteria

Exclusion criteria: 1.Age less than 18 years and more than 60 years. 2.Patient who are not willing to be included in the study. 3.Pregnant and Lactating women. 4.Patients with psoriatic arthropathy. 5.Patients with uncontrolled DM and HTN. 6.Patients with K/C/O severe heart diseases, kidney diseases, stroke, liver diseases, pulmonary dysfunction or COPD systemic illness like R.A., Gout, S.L.E., TB, AIDS, Other STDs etc. 7.Patients who is having other diseases and treatment which interferes the clinical trial. 8.Patients taking medications like corticosteroids, hormonal therapy, anti-depressants or any other drugs which may affect outcome of the study. 9.Patients with alcohol addiction or drug abuse.

Design outcomes

Primary

MeasureTime frame
Reduce Psoriatic patches, Itching, RednessTimepoint: within 20 days

Secondary

MeasureTime frame
Eradicate Psoriatic lesions, To give batter appearance of skinTimepoint: within 3 months

Countries

India

Contacts

Public ContactKrupaben Surubhai Kagda

Govindbhai Jorabhai Patel institute of Ayurvedic studies and research

manchak.kendre@cvmu.edu.in6354498349

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026